Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
Serruys PW, Sianos G, Abizaid A, Aoki J, den Heijer P, Bonnier H, Smits P, McClean D, Verheye S, Belardi J, Condado J, Pieper M, Gambone L, Bressers M, Symons J, Sousa E, Litvack F. Serruys PW, et al. Among authors: condado j. J Am Coll Cardiol. 2005 Jul 19;46(2):253-60. doi: 10.1016/j.jacc.2005.03.069. J Am Coll Cardiol. 2005. PMID: 16022951 Free article. Clinical Trial.
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES).
Aoki J, Ong AT, Abizaid A, den Heijer P, Bonnier H, McClean DR, Verheye S, Belardi J, Condado JA, Pieper M, Sousa JE, Bressers M, Symons J, Litvack F, Sianos G, Serruys PW. Aoki J, et al. Among authors: condado ja. EuroIntervention. 2005 Aug;1(2):165-72. EuroIntervention. 2005. PMID: 19758898
Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: the PLUS-ONE first-in-man study.
Calderas C, Condado JF, Condado JA, Flores A, Mueller A, Thomas J, Nakatani D, Honda Y, Waseda K, Fitzgerald P. Calderas C, et al. Among authors: condado ja, condado jf. Cardiovasc Revasc Med. 2014 Jan;15(1):18-22. doi: 10.1016/j.carrev.2013.10.001. Epub 2013 Oct 11. Cardiovasc Revasc Med. 2014. PMID: 24315045 Clinical Trial.
Two-year follow-up after intracoronary gamma radiation therapy.
Condado JA, Waksman R, Calderas C, Saucedo J, Lansky A. Condado JA, et al. Cardiovasc Radiat Med. 1999 Jan-Mar;1(1):30-5. doi: 10.1016/s1522-1865(98)00014-6. Cardiovasc Radiat Med. 1999. PMID: 11272353 Clinical Trial.
58 results